These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2547935)

  • 101. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A kappa opiate agonist, U50,488H, enhances energy expenditure in rats.
    Mandenoff A; Seyrig JA; Betoulle D; Brigant L; Melchior JC; Apfelbaum M
    Pharmacol Biochem Behav; 1991 May; 39(1):215-7. PubMed ID: 1656474
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    Brain Res; 1993 Jan; 600(1):151-5. PubMed ID: 8093675
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Identification of a novel class of highly potent sigma ligands related to the kappa-selective agonist U50,488.
    Radesca LA; deCosta BR; Bowen WD; DiPaolo LJ; Rice KC
    NIDA Res Monogr; 1990; 105():518-9. PubMed ID: 1652089
    [No Abstract]   [Full Text] [Related]  

  • 105. U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs.
    Tao PL; Hwang CL; Chen CY
    Eur J Pharmacol; 1994 May; 256(3):281-6. PubMed ID: 8045272
    [TBL] [Abstract][Full Text] [Related]  

  • 106. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse.
    Piercey MF; Lahti RA; Schroeder LA; Einspahr FJ; Barsuhn C
    Life Sci; 1982 Sep 20-27; 31(12-13):1197-200. PubMed ID: 6292608
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
    Tavani A; Gambino MC; Petrillo P
    J Pharm Pharmacol; 1984 May; 36(5):343-4. PubMed ID: 6145777
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
    Bhargava HN; Thorat SN
    Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
    Jackson A; Cooper SJ
    Brain Res Bull; 1985 Oct; 15(4):391-6. PubMed ID: 2998563
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1992; 106(1):31-8. PubMed ID: 1346721
    [TBL] [Abstract][Full Text] [Related]  

  • 111. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Interaction between the cardiovascular effects of clonidine and the kappa-opioid agonist U-50,488H in the anterior hypothalamic area of the rat brain.
    Verberne AJ; Louis WJ
    J Pharm Pharmacol; 1989 Feb; 41(2):131-3. PubMed ID: 2568424
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
    Leander JD
    Appetite; 1984 Mar; 5(1):7-14. PubMed ID: 6091543
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation.
    Peiró AM; Climent L; Zapater P; Horga A; Horga JF
    Pharmacol Res; 2011 Jul; 64(1):80-4. PubMed ID: 21420495
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments.
    Lason W; Simpson JN; McGinty JF
    Brain Res; 1989 Mar; 482(2):333-9. PubMed ID: 2539886
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Naloxone produces protracted tolerance in mice treated with a single dose of morphine.
    Sofuoglu M; Takemori AE
    J Pharmacol Exp Ther; 1990 Sep; 254(3):836-40. PubMed ID: 2395115
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Peripheral kappa 1-opioid receptor-mediated analgesia in mice.
    Kolesnikov Y; Jain S; Wilson R; Pasternak GW
    Eur J Pharmacol; 1996 Aug; 310(2-3):141-3. PubMed ID: 8884210
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH; Collins RJ
    Psychopharmacology (Berl); 1985; 85(3):309-14. PubMed ID: 3923516
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Antagonism of U-50,488H-induced antinociception by ginseng total saponins is dependent on serotonergic mechanisms.
    Kim HS; Oh KW; Rheu HM; Kim SH
    Pharmacol Biochem Behav; 1992 Aug; 42(4):587-93. PubMed ID: 1513840
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Effect of chronic administration of dihydropyridine Ca2+ channel ligands on sufentanil-induced tolerance to mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    Regul Pept; 1996 May; 63(1):1-8. PubMed ID: 8795082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.